Penumbra Inc (PEN) earnings · P/E 80, rev $1.40B
These earnings events as JSON? API free 100/dayPenumbra Inc (PEN) is a medical devices company listed on US.
This PEN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported PEN revenue for 2025-12-31 was $1.40B. Net income was $177.7M. Revenue was up 17.5% from 2024-12-31 to 2025-12-31. PEN currently screens at market cap $9.93B and trailing P/E 79.7.
When the next PEN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 17.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full PEN research stays on the stock page; the tape stays on the quote page.
PEN earnings FAQ
What are PEN's latest revenue and net income?
Latest cached Penumbra Inc (PEN) revenue for Dec 31, 2025 was $1.40B. Net income was $177.7M. Statements: https://lician.com/financials/pen
What is PEN's latest diluted EPS?
Latest cached Penumbra Inc (PEN) diluted EPS for Dec 31, 2025 was $4.52.
What period does the latest PEN earnings print cover?
The latest cached Penumbra Inc (PEN) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did PEN revenue change from the prior cached period?
Cached Penumbra Inc (PEN) revenue was up 17.5% from $1.19B (Dec 31, 2024) to $1.40B (Dec 31, 2025). Statements: https://lician.com/financials/pen
What is PEN's P/E ratio?
Penumbra Inc (PEN) trailing P/E is 79.7 on the latest cached fundamentals snapshot.
Where are PEN earnings listed?
Cached earnings facts for Penumbra Inc (PEN) are listed at https://lician.com/earnings/pen. Statements: https://lician.com/financials/pen
Not investment advice.